CCAAT/enhancer-binding protein δ is a critical mediator of lipopolysaccharide-induced acute lung injury

American Journal of Pathology

Volumn 182, Issue 2, 2013, Pages 420-430

  Yan, Chunguang ^a   Johnson, Peter F ^b   Tang, Huifang ^a   Ye, Yan ^c   Wu, Min ^c   Gao, Hongwei ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

^c UNIVERSITY OF NORTH DAKOTA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; CCAAT ENHANCER BINDING PROTEIN BETA; CCAAT ENHANCER BINDING PROTEIN DELTA; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; MACROPHAGE INFLAMMATORY PROTEIN 2; MYELOPEROXIDASE; TUMOR NECROSIS FACTOR ALPHA;

ACUTE LUNG INJURY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; GEL MOBILITY SHIFT ASSAY; GENE DELETION; LEUKOCYTE COUNT; LUNG HEMORRHAGE; LUNG LAVAGE; LUNG STRUCTURE; MACROPHAGE; MALE; MOUSE; NEUTROPHIL; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ACUTE LUNG INJURY; ANIMALS; BRONCHOALVEOLAR LAVAGE FLUID; CCAAT-ENHANCER-BINDING PROTEIN-DELTA; CELL LINE; CHEMOKINES; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; GENE KNOCKDOWN TECHNIQUES; INTERLEUKIN-6; LIPOPOLYSACCHARIDES; LUCIFERASES; LUNG; MACROPHAGES, ALVEOLAR; MICE; MITOGEN-ACTIVATED PROTEIN KINASE 3; P38 MITOGEN-ACTIVATED PROTEIN KINASES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84872694467     PISSN: 00029440     EISSN: 15252191     Source Type: Journal    
DOI: 10.1016/j.ajpath.2012.10.013     Document Type: Article

References (55)

1. K. Tsushima, L.S. King, N.R. Aggarwal, A. De Gorordo, F.R. D'Alessio, and K. Kubo Acute lung injury review Intern Med 48 2009 621 630
2. M. Chopra, J.S. Reuben, and A.C. Sharma Acute lung injury: apoptosis and signaling mechanisms Exp Biol Med (Maywood) 234 2009 361 371
3. S.E. Erickson, G.S. Martin, J.L. Davis, M.A. Matthay, and M.D. Eisner Recent trends in acute lung injury mortality: 1996-2005 Crit Care Med 37 2009 1574 1579
4. G.D. Rubenfeld, E. Caldwell, E. Peabody, J. Weaver, D.P. Martin, M. Neff, E.J. Stern, and L.D. Hudson Incidence and outcomes of acute lung injury N Engl J Med 353 2005 1685 1693
5. H. Gao, R.F. Guo, C.L. Speyer, J. Reuben, T.A. Neff, L.M. Hoesel, N.C. Riedemann, S.D. McClintock, J.V. Sarma, N. Van Rooijen, F.S. Zetoune, and P.A. Ward Stat3 activation in acute lung injury J Immunol 172 2004 7703 7712
6. R.F. Guo, A.B. Lentsch, J.V. Sarma, L. Sun, N.C. Riedemann, S.D. McClintock, S.R. McGuire, N. Van Rooijen, and P.A. Ward Activator protein-1 activation in acute lung injury Am J Pathol 161 2002 275 282
7. A.B. Lentsch, B.J. Czermak, N.M. Bless, and P.A. Ward NF-kappaB activation during IgG immune complex-induced lung injury: requirements for TNF-alpha and IL-1beta but not complement Am J Pathol 152 1998 1327 1336
8. A.B. Lentsch, T.P. Shanley, V. Sarma, and P.A. Ward In vivo suppression of NF-kappa B and preservation of I kappa B alpha by interleukin-10 and interleukin-13 J Clin Invest 100 1997 2443 2448
9. J. Fan, R.D. Ye, and A.B. Malik Transcriptional mechanisms of acute lung injury Am J Physiol Lung Cell Mol Physiol 281 2001 L1037 L1050
10. J. Lekstrom-Himes, and K.G. Xanthopoulos Biological role of the CCAAT/enhancer-binding protein family of transcription factors J Biol Chem 273 1998 28545 28548
11. V. Poli The role of C/EBP isoforms in the control of inflammatory and native immunity functions J Biol Chem 273 1998 29279 29282
12. J. Tsukada, Y. Yoshida, Y. Kominato, and P.E. Auron The CCAAT/enhancer (C/EBP) family of basic-leucine zipper (bZIP) transcription factors is a multifaceted highly-regulated system for gene regulation Cytokine 54 2011 6 19
13. M. Cappelletti, T. Alonzi, E. Fattori, C. Libert, and V. Poli C/EBPbeta is required for the late phases of acute phase genes induction in the liver and for tumour necrosis factor-alpha, but not interleukin-6, regulation Cell Death Differ 3 1996 29 35
14. B. Gorgoni, D. Maritano, P. Marthyn, M. Righi, and V. Poli C/EBP beta gene inactivation causes both impaired and enhanced gene expression and inverse regulation of IL-12 p40 and p35 mRNAs in macrophages J Immunol 168 2002 4055 4062
15. O. Kozawa, T. Otsuka, and T. Uematsu Leukemia inhibitory factor enhances bFGF-induced IL-6 synthesis in osteoblasts: involvement of JAK2/STAT3 Cell Signal 14 2002 311 315
16. T.E. Adams, J.A. Hansen, R. Starr, N.A. Nicola, D.J. Hilton, and N. Billestrup Growth hormone preferentially induces the rapid, transient expression of SOCS-3, a novel inhibitor of cytokine receptor signaling J Biol Chem 273 1998 1285 1287
17. M. Caivano, B. Gorgoni, P. Cohen, and V. Poli The induction of cyclooxygenase-2 mRNA in macrophages is biphasic and requires both CCAAT enhancer-binding protein beta (C/EBP beta) and C/EBP delta transcription factors J Biol Chem 276 2001 48693 48701
18. J.E. Albina, E.J. Mahoney, J.M. Daley, D.E. Wesche, S.M. Morris Jr., and J.S. Reichner Macrophage arginase regulation by CCAAT/enhancer-binding protein beta Shock 23 2005 168 172
19. B.P. Howden, P.B. Ward, P.D. Johnson, P.G. Charles, and M.L. Grayson Low-level vancomycin resistance in Staphylococcus aureus: an Australian perspective Eur J Clin Microbiol Infect Dis 24 2005 100 108
20. Y. Fong, K.H. Shen, L.J. Chen, and J.T. Cheng Changes of CCAAT enhancer-binding proteins (CEBPs) in the lung of streptozotocin-induced diabetic rats Horm Metab Res 43 2011 261 267
21. W. Browder, T. Ha, L. Chuanfu, J.H. Kalbfleisch, D.A. Ferguson Jr., and D.L. Williams Early activation of pulmonary nuclear factor kappaB and nuclear factor interleukin-6 in polymicrobial sepsis J Trauma 46 1999 590 596
22. N. Miglino, M. Roth, D. Lardinois, C. Sadowski, M. Tamm, and P. Borger Cigarette smoke inhibits lung fibroblast proliferation by translational mechanisms Eur Respir J 39 2012 705 711
23. T. Tanaka, N. Yoshida, T. Kishimoto, and S. Akira Defective adipocyte differentiation in mice lacking the C/EBPbeta and/or C/EBPdelta gene EMBO J 16 1997 7432 7443
24. B.L. Burgess-Beusse, and G.J. Darlington C/EBPalpha is critical for the neonatal acute-phase response to inflammation Mol Cell Biol 18 1998 7269 7277
25. T. Alam, M.R. An, and J. Papaconstantinou Differential expression of three C/EBP isoforms in multiple tissues during the acute phase response J Biol Chem 267 1992 5021 5024
26. S.H. Slofstra, A.P. Groot, M.H. Obdeijn, P.H. Reitsma, H. ten Cate, and C.A. Spek Gene expression profiling identifies C/EBPdelta as a candidate regulator of endotoxin-induced disseminated intravascular coagulation Am J Respir Crit Care Med 176 2007 602 609
27. L. Didon, J.L. Barton, A.B. Roos, G.J. Gaschler, C.M. Bauer, T. Berg, M.R. Stampfli, and M. Nord Lung epithelial CCAAT/enhancer-binding protein-β is necessary for the integrity of inflammatory responses to cigarette smoke Am J Respir Crit Care Med 184 2011 233 242
28. B. Hu, M.R. Ullenbruch, H. Jin, M. Gharaee-Kermani, and S.H. Phan An essential role for CCAAT/enhancer binding protein beta in bleomycin-induced pulmonary fibrosis J Pathol 211 2007 455 462
29. E. Sterneck, L. Tessarollo, and P.F. Johnson An essential role for C/EBPbeta in female reproduction Genes Dev 11 1997 2153 2162
30. E. Sterneck, R. Paylor, V. Jackson-Lewis, M. Libbey, S. Przedborski, L. Tessarollo, J.N. Crawley, and P.F. Johnson Selectively enhanced contextual fear conditioning in mice lacking the transcriptional regulator CCAAT/enhancer binding protein delta Proc Natl Acad Sci U S A 95 1998 10908 10913
31. N. Van Rooijen, and A. Sanders Liposome mediated depletion of macrophages: mechanism of action, preparation of liposomes and applications J Immunol Methods 174 1994 83 93
32. H. Gao, S. Parkin, P.F. Johnson, and R.C. Schwartz C/EBP gamma has a stimulatory role on the IL-6 and IL-8 promoters J Biol Chem 277 2002 38827 38837
33. H.M. Hu, M. Baer, S.C. Williams, P.F. Johnson, and R.C. Schwartz Redundancy of C/EBP alpha, -beta, and -delta in supporting the lipopolysaccharide-induced transcription of IL-6 and monocyte chemoattractant protein-1 J Immunol 160 1998 2334 2342
34. P. Descombes, and U. Schibler A liver-enriched transcriptional activator protein, LAP, and a transcriptional inhibitory protein LIP, are translated from the same mRNA Cell 67 1991 569 579
35. M.A. Koay, X. Gao, M.K. Washington, K.S. Parman, R.T. Sadikot, T.S. Blackwell, and J.W. Christman Macrophages are necessary for maximal nuclear factor-kappa B activation in response to endotoxin Am J Respir Cell Mol Biol 26 2002 572 578
36. V. Litvak, S.A. Ramsey, A.G. Rust, D.E. Zak, K.A. Kennedy, A.E. Lampano, M. Nykter, I. Shmulevich, and A. Aderem Function of C/EBPdelta in a regulatory circuit that discriminates between transient and persistent TLR4-induced signals Nat Immunol 10 2009 437 443
37. L. Sun, R.F. Guo, H. Gao, J.V. Sarma, F.S. Zetoune, and P.A. Ward Attenuation of IgG immune complex-induced acute lung injury by silencing C5aR in lung epithelial cells FASEB J 23 2009 3808 3818
38. E.T. Rietschel, T. Kirikae, F.U. Schade, U. Mamat, G. Schmidt, H. Loppnow, A.J. Ulmer, U. Zähringer, U. Seydel, F. Di Padova, M. Schreier, and H. Brade Bacterial endotoxin: molecular relationships of structure to activity and function FASEB J 8 1994 217 225
39. N.P. O'Grady, H.L. Preas, J. Pugin, C. Fiuza, M. Tropea, D. Reda, S.M. Banks, and A.F. Suffredini Local inflammatory responses following bronchial endotoxin instillation in humans Am J Respir Crit Care Med 163 2001 1591 1598
40. K. Kabir, J.P. Gelinas, M. Chen, D. Chen, D. Zhang, X. Luo, J.H. Yang, D. Carter, and R. Rabinovici Characterization of a murine model of endotoxin-induced acute lung injury Shock 17 2002 300 303
41. G. Matute-Bello, C.W. Frevert, and T.R. Martin Animal models of acute lung injury Am J Physiol Lung Cell Mol Physiol 295 2008 L379 L399
42. T. Tanaka, S. Akira, K. Yoshida, M. Umemoto, Y. Yoneda, N. Shirafuji, H. Fujiwara, S. Suematsu, N. Yoshida, and T. Kishimoto Targeted disruption of the NF-IL6 gene discloses its essential role in bacteria killing and tumor cytotoxicity by macrophages Cell 80 1995 353 361
43. S. Uematsu, T. Kaisho, T. Tanaka, M. Matsumoto, M. Yamakami, H. Omori, M. Yamamoto, T. Yoshimori, and S. Akira The C/EBP beta isoform 34-kDa LAP is responsible for NF-IL-6-mediated gene induction in activated macrophages, but is not essential for intracellular bacteria killing J Immunol 179 2007 5378 5386
44. M. Matsumoto, T. Tanaka, T. Kaisho, H. Sanjo, N.G. Copeland, D.J. Gilbert, N.A. Jenkins, and S. Akira A novel LPS-inducible C-type lectin is a transcriptional target of NF-IL6 in macrophages J Immunol 163 1999 5039 5048
45. S. Uematsu, M. Matsumoto, K. Takeda, and S. Akira Lipopolysaccharide- dependent prostaglandin E(2) production is regulated by the glutathione- dependent prostaglandin E(2) synthase gene induced by the Toll-like receptor 4/MyD88/NF-IL6 pathway J Immunol 168 2002 5811 5816
46. Y.C. Lu, I. Kim, E. Lye, F. Shen, N. Suzuki, S. Suzuki, S. Gerondakis, S. Akira, S.L. Gaffen, W.C. Yeh, and P.S. Ohashi Differential role for c-Rel and C/EBPbeta/delta in TLR-mediated induction of proinflammatory cytokines J Immunol 182 2009 7212 7221
47. S. Kinoshita, S. Akira, and T. Kishimoto A member of the C/EBP family, NF-IL6 beta, forms a heterodimer and transcriptionally synergizes with NF-IL6 Proc Natl Acad Sci U S A 89 1992 1473 1476
48. D.S. Cheng, W. Han, S.M. Chen, T.P. Sherrill, M. Chont, G.Y. Park, J.R. Sheller, V.V. Polosukhin, J.W. Christman, F.E. Yull, and T.S. Blackwell Airway epithelium controls lung inflammation and injury through the NF-kappa B pathway J Immunol 178 2007 6504 6513
49. H.M. Hu, Q. Tian, M. Baer, C.J. Spooner, S.C. Williams, P.F. Johnson, and R.C. Schwartz The C/EBP bZIP domain can mediate lipopolysaccharide induction of the proinflammatory cytokines interleukin-6 and monocyte chemoattractant protein-1 J Biol Chem 275 2000 16373 16381
50. B. Stein, and A.S. Baldwin Jr. Distinct mechanisms for regulation of the interleukin-8 gene involve synergism and cooperativity between C/EBP and NF-kappa B Mol Cell Biol 13 1993 7191 7198
51. N. Hashimoto, T. Kawabe, K. Imaizumi, T. Hara, M. Okamoto, K. Kojima, K. Shimokata, and Y. Hasegawa CD40 plays a crucial role in lipopolysaccharide- induced acute lung injury Am J Respir Cell Mol Biol 30 2004 808 815
52. S. Kannan, H. Huang, D. Seeger, A. Audet, Y. Chen, C. Huang, H. Gao, S. Li, and M. Wu Alveolar epithelial type II cells activate alveolar macrophages and mitigate P. aeruginosa infection PLoS One 4 2009 e4891
53. J.N. Vanderbilt, E.M. Mager, L. Allen, T. Sawa, J. Wiener-Kronish, R. Gonzalez, and L.G. Dobbs CXC chemokines and their receptors are expressed in type II cells and upregulated following lung injury Am J Respir Cell Mol Biol 29 2003 661 668
54. A.J. Thorley, P. Goldstraw, A. Young, and T.D. Tetley Primary human alveolar type II epithelial cell CCL20 (macrophage inflammatory protein-3alpha)-induced dendritic cell migration Am J Respir Cell Mol Biol 32 2005 262 267
55. K. Sato, H. Tomioka, T. Shimizu, T. Gonda, F. Ota, and C. Sano Type II alveolar cells play roles in macrophage-mediated host innate resistance to pulmonary mycobacterial infections by producing proinflammatory cytokines J Infect Dis 185 2002 1139 1147